title: Gemcitabine (GEM), 5-fluorouracil (5-FU) and folinic acid (FA) in patients with different gastroenteric malignancies.
abstract: This phase II clinical trial was performed in order to evaluate the pharmacokinetics, toxicity and anti-tumor activity of a novel combination of gemcitabine (GEM), 5-fluorouracil (5-FU) and folinic acid (FA) designed on a specific translational basis. Every 4 weeks, 44 patients with various gastroenteric malignancies, 29 of whom had pancreas carcinoma, received a short intravenous (i.v.) infusion of FA (100 mg/m2) and 5-FU (400 mg/m2) on days 1-5, and GEM 1000 mg/m2 on days 1, 8 and 16. Our results suggest that, although this treatment leads to hematological and gastroenteric toxicity, it is very active in patients with pancreatic carcinoma. We therefore believe that an improved version would merit further investigation in larger scale trials.
authors.affiliation: Oncology Section, Department of Human Pathology and Oncology, Siena University School of Medicine, Siena, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Correale
authors.forename: D
authors.initials: D
authors.lastname: Cerretani
authors.forename: M
authors.initials: M
authors.lastname: Clerici
authors.forename: S
authors.initials: S
authors.lastname: Messinese
authors.forename: S
authors.initials: S
authors.lastname: Marsili
authors.forename: R
authors.initials: R
authors.lastname: Petrioli
authors.forename: F
authors.initials: F
authors.lastname: Cetta
authors.forename: V
authors.initials: V
authors.lastname: Savelli
authors.forename: A
authors.initials: A
authors.lastname: Guarnieri
authors.forename: E
authors.initials: E
authors.lastname: Pinto
authors.forename: G
authors.initials: G
authors.lastname: Giorgi
authors.forename: G
authors.initials: G
authors.lastname: Francini
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000556:secondary; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D004067:Digestive System Neoplasms / Q000188:drug therapy* / Q000473:pathology; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007262:Infusions, Intravenous; D002955:Leucovorin / Q000008:administration & dosage; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D000093542:Gemcitabine
chemical_list: D003841:Deoxycytidine; D002955:Leucovorin; D005472:Fluorouracil; D000093542:Gemcitabine